142 related articles for article (PubMed ID: 24324527)
1. Transcriptional protein-protein cooperativity in POU/HMG/DNA complexes revealed by normal mode analysis.
Wang DD; Yan H
Comput Math Methods Med; 2013; 2013():854710. PubMed ID: 24324527
[TBL] [Abstract][Full Text] [Related]
2. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.
Botquin V; Hess H; Fuhrmann G; Anastassiadis C; Gross MK; Vriend G; Schöler HR
Genes Dev; 1998 Jul; 12(13):2073-90. PubMed ID: 9649510
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.
Ambrosetti DC; Basilico C; Dailey L
Mol Cell Biol; 1997 Nov; 17(11):6321-9. PubMed ID: 9343393
[TBL] [Abstract][Full Text] [Related]
4. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
[TBL] [Abstract][Full Text] [Related]
5. Quantitative profiling of selective Sox/POU pairing on hundreds of sequences in parallel by Coop-seq.
Chang YK; Srivastava Y; Hu C; Joyce A; Yang X; Zuo Z; Havranek JJ; Stormo GD; Jauch R
Nucleic Acids Res; 2017 Jan; 45(2):832-845. PubMed ID: 27915232
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y.
Leger H; Sock E; Renner K; Grummt F; Wegner M
Mol Cell Biol; 1995 Jul; 15(7):3738-47. PubMed ID: 7791781
[TBL] [Abstract][Full Text] [Related]
7. Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors.
Smit DJ; Smith AG; Parsons PG; Muscat GE; Sturm RA
Eur J Biochem; 2000 Nov; 267(21):6413-22. PubMed ID: 11029584
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer.
Ambrosetti DC; Schöler HR; Dailey L; Basilico C
J Biol Chem; 2000 Jul; 275(30):23387-97. PubMed ID: 10801796
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers.
Reményi A; Lins K; Nissen LJ; Reinbold R; Schöler HR; Wilmanns M
Genes Dev; 2003 Aug; 17(16):2048-59. PubMed ID: 12923055
[TBL] [Abstract][Full Text] [Related]
10. POU/TBP cooperativity: a mechanism for enhancer action from a distance.
Bertolino E; Singh H
Mol Cell; 2002 Aug; 10(2):397-407. PubMed ID: 12191484
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray analysis of human Brn-5 transcription factor in complex with DNA.
Pereira JH; Ha SC; Kim SH
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Mar; 64(Pt 3):175-8. PubMed ID: 18323601
[TBL] [Abstract][Full Text] [Related]
12. Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells.
Tanaka S; Kamachi Y; Tanouchi A; Hamada H; Jing N; Kondoh H
Mol Cell Biol; 2004 Oct; 24(20):8834-46. PubMed ID: 15456859
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the POU-specific DNA-binding domain of Oct-1.
Dekker N; Cox M; Boelens R; Verrijzer CP; van der Vliet PC; Kaptein R
Nature; 1993 Apr; 362(6423):852-5. PubMed ID: 8479524
[TBL] [Abstract][Full Text] [Related]
14. Fine-tuning of intrinsic N-Oct-3 POU domain allostery by regulatory DNA targets.
Alazard R; Mourey L; Ebel C; Konarev PV; Petoukhov MV; Svergun DI; Erard M
Nucleic Acids Res; 2007; 35(13):4420-32. PubMed ID: 17576670
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9.
Kamachi Y; Cheah KS; Kondoh H
Mol Cell Biol; 1999 Jan; 19(1):107-20. PubMed ID: 9858536
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures.
Nieto L; Joseph G; Stella A; Henri P; Burlet-Schiltz O; Monsarrat B; Clottes E; Erard M
J Mol Biol; 2007 Jul; 370(4):687-700. PubMed ID: 17543985
[TBL] [Abstract][Full Text] [Related]
17. Oct-1 POU domain-DNA interactions: cooperative binding of isolated subdomains and effects of covalent linkage.
Klemm JD; Pabo CO
Genes Dev; 1996 Jan; 10(1):27-36. PubMed ID: 8557192
[TBL] [Abstract][Full Text] [Related]
18. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.
Yuan H; Corbi N; Basilico C; Dailey L
Genes Dev; 1995 Nov; 9(21):2635-45. PubMed ID: 7590241
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel domains within Sox-2 and Sox-11 involved in autoinhibition of DNA binding and partnership specificity.
Wiebe MS; Nowling TK; Rizzino A
J Biol Chem; 2003 May; 278(20):17901-11. PubMed ID: 12637543
[TBL] [Abstract][Full Text] [Related]
20. Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming.
Malik V; Zimmer D; Jauch R
Cell Mol Life Sci; 2018 May; 75(9):1587-1612. PubMed ID: 29335749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
